Latest Breaking News On - அவசரம் பயன்பாடு விண்ணப்பம் - Page 1 : comparemela.com

QIAGEN N.V.: QIAGEN Launches artus Prep&Amp as CE-Marked SARS-CoV-2 Test Offering up to Threefold Increase in Daily Lab Testing Capacity CE-IVD marking for Europe and other countries worldwide, EUA (Emergency Use Application) submission made in the U.S. Streamlined workflow cuts costs and plastic usage offering time to result of about two hours QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of the artus SARS-CoV-2 Prep&Amp UM Kit which uses a liquid based sample preparation technology to simplify and increase COVID-19 testing throughput. The artus SARS-CoV-2 Prep&Amp UM Kit has been CE-IVD registered for use in the European Union and other markets and an application for Emergency Use Authorization (EUA) has been submitted to the FDA, allowing commercialization via notification in the US.

John gilardiRobert reitzeJean pascal violaThomas theuringerPhoebe lohExchange commissionEuropean unionLife sciencesCorporate business developmentUs securities exchangePrep ampEmergency use applicationFrankfurt prime standardEmergency use authorizationUniversal transport mediaSenior vice president